The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer

Cervical cancer is the fourth leading cause of cancer-related death among women worldwide. The chemotherapeutical agent cisplatin, a small platinum-based compound, is considered as the standard therapy for locally advanced cervical cancer or recurrent cancers, sometimes in combination with radiother...

Full description

Bibliographic Details
Main Authors: Rina Masadah, Syahrul Rauf, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/5/1168
_version_ 1797542135126294528
author Rina Masadah
Syahrul Rauf
Muhammad Yogi Pratama
Claudio Tiribelli
Devis Pascut
author_facet Rina Masadah
Syahrul Rauf
Muhammad Yogi Pratama
Claudio Tiribelli
Devis Pascut
author_sort Rina Masadah
collection DOAJ
description Cervical cancer is the fourth leading cause of cancer-related death among women worldwide. The chemotherapeutical agent cisplatin, a small platinum-based compound, is considered as the standard therapy for locally advanced cervical cancer or recurrent cancers, sometimes in combination with radiotherapy or other drugs. However, drug resistance and radio-resistance phenomena could reduce the life expectancy of cervical cancer patients. Resistance mechanisms are complex and often involve multiple cellular pathways in which microRNAs (miRNAs) play a fundamental role. miRNAs are a class of endogenous non-coding small RNAs responsible for post-transcriptional gene regulation. Convincing evidence demonstrates that several deregulated miRNAs are important regulators in the onset of drug and radioresistance in cervical cancer, thus underlying their potential applications in a clinical setting. In this review, we summarized the mechanisms by which miRNAs affect both cisplatin and radioresistance in cervical cancer. We also described the regulatory loops between miRNAs and lncRNAs promoting drug resistance. Besides, we reported evidence for the role of miRNAs in sensitizing cancer cells to cisplatin-based chemotherapy, and provided some suggestions for the development of new combined therapies for cervical cancer.
first_indexed 2024-03-10T13:25:25Z
format Article
id doaj.art-af10f8fdc2c54a9bb0b8cf0f703fb8a8
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T13:25:25Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-af10f8fdc2c54a9bb0b8cf0f703fb8a82023-11-21T09:41:16ZengMDPI AGCancers2072-66942021-03-01135116810.3390/cancers13051168The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical CancerRina Masadah0Syahrul Rauf1Muhammad Yogi Pratama2Claudio Tiribelli3Devis Pascut4Department of Pathology Anatomy, Hasanuddin University, Makassar 90245, IndonesiaDepartment of Obstetrics and Gynecology, Hasanuddin University, Makassar 90245, IndonesiaDepartment of Pathology Anatomy, Hasanuddin University, Makassar 90245, IndonesiaLiver Research Center, Fondazione Italiana Fegato—ONLUS, Basovizza, 34149 Trieste, ItalyLiver Research Center, Fondazione Italiana Fegato—ONLUS, Basovizza, 34149 Trieste, ItalyCervical cancer is the fourth leading cause of cancer-related death among women worldwide. The chemotherapeutical agent cisplatin, a small platinum-based compound, is considered as the standard therapy for locally advanced cervical cancer or recurrent cancers, sometimes in combination with radiotherapy or other drugs. However, drug resistance and radio-resistance phenomena could reduce the life expectancy of cervical cancer patients. Resistance mechanisms are complex and often involve multiple cellular pathways in which microRNAs (miRNAs) play a fundamental role. miRNAs are a class of endogenous non-coding small RNAs responsible for post-transcriptional gene regulation. Convincing evidence demonstrates that several deregulated miRNAs are important regulators in the onset of drug and radioresistance in cervical cancer, thus underlying their potential applications in a clinical setting. In this review, we summarized the mechanisms by which miRNAs affect both cisplatin and radioresistance in cervical cancer. We also described the regulatory loops between miRNAs and lncRNAs promoting drug resistance. Besides, we reported evidence for the role of miRNAs in sensitizing cancer cells to cisplatin-based chemotherapy, and provided some suggestions for the development of new combined therapies for cervical cancer.https://www.mdpi.com/2072-6694/13/5/1168cervical cancercisplatinmicroRNAdrug resistanceradiotherapycisplatin resistance
spellingShingle Rina Masadah
Syahrul Rauf
Muhammad Yogi Pratama
Claudio Tiribelli
Devis Pascut
The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
Cancers
cervical cancer
cisplatin
microRNA
drug resistance
radiotherapy
cisplatin resistance
title The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
title_full The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
title_fullStr The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
title_full_unstemmed The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
title_short The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
title_sort role of micrornas in the cisplatin and radio resistance of cervical cancer
topic cervical cancer
cisplatin
microRNA
drug resistance
radiotherapy
cisplatin resistance
url https://www.mdpi.com/2072-6694/13/5/1168
work_keys_str_mv AT rinamasadah theroleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT syahrulrauf theroleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT muhammadyogipratama theroleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT claudiotiribelli theroleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT devispascut theroleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT rinamasadah roleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT syahrulrauf roleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT muhammadyogipratama roleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT claudiotiribelli roleofmicrornasinthecisplatinandradioresistanceofcervicalcancer
AT devispascut roleofmicrornasinthecisplatinandradioresistanceofcervicalcancer